Cargando…
Myxoid liposarcoma: a well-defined clinical target variant in radiotherapy for soft tissue sarcoma
Autor principal: | Yu, Jeong Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society for Radiation Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830037/ https://www.ncbi.nlm.nih.gov/pubmed/36606298 http://dx.doi.org/10.3857/roj.2022.00598 |
Ejemplares similares
-
TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities
por: Koelsche, Christian, et al.
Publicado: (2014) -
Safely combining trabectedin with radiotherapy to treat myxoid liposarcoma
por: Chen, Mark, et al.
Publicado: (2019) -
Histological response to radiotherapy is an early event in myxoid liposarcoma
por: Lam, Suk Wai, et al.
Publicado: (2023) -
Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): Results of a Phase I Study in Myxoid Liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) Sarcoma Groups
por: Gronchi, Alessandro, et al.
Publicado: (2019) -
Cytogenetics and Molecular Genetics of Myxoid Soft-Tissue Sarcomas
por: Nishio, Jun, et al.
Publicado: (2011)